CIBC Private Wealth Group
CRBP icon

CIBC Private Wealth Group’s Corbus Pharmaceuticals CRBP Stock Holding History

CIBC Private Wealth Group’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1
Closed -$7 – 3135
2025
Q2 		$7 Hold
1
– – ﹤0.01% 3053
2025
Q1 		$5 Hold
1
– – ﹤0.01% 3060
2024
Q4 		$12 Hold
1
– – ﹤0.01% 2945
2024
Q3 		$21 Hold
1
– – ﹤0.01% 3079
2024
Q2 		$51 Hold
1
– – ﹤0.01% 3103
2024
Q1 		$38 Buy
+1
New +$25 ﹤0.01% 3027
2018
Q3 		– Sell
-2
Closed – – 1108
2018
Q2 		$0 Hold
2
– – ﹤0.01% 1980
2018
Q1 		$0 Sell
2
-4,850
-100% -$1.09M ﹤0.01% 1960
2017
Q4 		$1.03M Buy
4,852
+69
+1% +$14.8K ﹤0.01% 646
2017
Q3 		$1.03M Hold
4,783
– – ﹤0.01% 639
2017
Q2 		$904K Hold
4,783
– – 0.01% 482
2017
Q1 		$1.18M Hold
4,783
– – 0.01% 433
2016
Q4 		$1.21M Buy
+4,783
New +$1.1M 0.01% 435

Other funds holding CRBP

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
EAM
Exome Asset Management New York $193M AUM 208.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Comerica Bank
Comerica Bank Dallas, Texas $25.1B AUM 24.68% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

CIBC Private Wealth Group's CRBP Position: Q3 2025 in Review

CIBC Private Wealth Group sold out of Corbus Pharmaceuticals (CRBP) in Q3 2025, closing a stake of 1 share — an estimated $7 sold.

CIBC Private Wealth Group first reported a position in CRBP in Q4 2016 and held it in 13 quarters. The position peaked at $1.21M in Q4 2016. 81 funds tracked by Wall St. Rank hold CRBP as of Q3 2025.

  • CIBC Private Wealth Group reported no remaining Corbus Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • CIBC Private Wealth Group sold 1 Corbus Pharmaceuticals share in Q3 2025, an estimated $7.
  • CIBC Private Wealth Group first reported a position in Corbus Pharmaceuticals in Q4 2016 and held it in 13 quarters.
  • CIBC Private Wealth Group's Corbus Pharmaceuticals position peaked at $1.21M in Q4 2016.
  • 81 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2025.

Based on CIBC Private Wealth Group's 13F filing for Q3 2025, filed 24 Nov 2025.